Minimal Activity of Single-Agent Nivolumab in Relapsed/Refractory Follicular Lymphoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood